Methods of treatment of amyloidosis using bi-aryl aspartyl protease inhibitors
申请人:John Varghese
公开号:US20060014737A1
公开(公告)日:2006-01-19
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
[EN] N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INHIBITORS<br/>[FR] CARBOXAMIDES N-PYRAZOLYL EN TANT QU'INHIBITEURS DU CANAL CRAC
申请人:GLAXO GROUP LTD
公开号:WO2010122089A1
公开(公告)日:2010-10-28
The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.
formation of organozincreagents and subsequent cross-coupling with aryl halides and activated carboxylic acids is reported. Formation of organozincreagents is achieved by pumping organic halides, in the presence of ZnCl2 and LiCl, through an activated Mg-packed column under flow conditions. This method provides efficient in situ formation of aryl, primary, secondary, and tertiary alkyl organozinc reagents
The present invention relates to compounds of formula (I) that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.
[EN] LUMINESCENT DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES<br/>[FR] COMPLEXES DIAZABENZIMIDAZOLE CARBÈNE-MÉTAL LUMINESCENTS
申请人:BASF SE
公开号:WO2015014835A1
公开(公告)日:2015-02-05
The present invention relates to metal-carbene complexes of the general formula (I), where variable M is Ir or Pt and that are characterized by variable R being a group of formula (a). The complexes are used in organic electronic devices, especially OLEDs (Organic Light-Emitting Diodes), illuminating elements, stationary visual display units and in material layers as emitter, charge transport material and/or charge or exiton blocker.